Haleon plc(HLN)Earnings, Financials & Key RatiosHaleon plc (HLN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q4
while the company shows strong cash generation with a 22.8% free cash flow margin, the stagnant revenue growth of -0.4% and a tight current ratio of 0.92 suggest that investors should wait for signs of top-line stabilization.
Haleon plc (HLN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Haleon plc (HLN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 25, 2026 | $0.26vs $0.25+3.4% | $7.5Bvs $7.6B-0.8% |
| Q4 2025 | Oct 30, 2025 | $0.14vs $0.24-42.8% | $7.5Bvs $2.8B+171.9% |
| Q3 2025 | Aug 7, 2025 | $0.08vs $0.24-67.3% | $7.3Bvs $2.8B+162.4% |
| Q1 2025 | Feb 27, 2025 | $0.05vs $25.25-99.8% | $7.1Bvs $2.7B+161.2% |
Recent stock market news and headlines for Haleon plc (HLN)
Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?
Haleon plc (NYSE:HLN) has entered into a new five-year collaboration with Microsoft Corp. (NASDAQ:MSFT) to expand its digital, data, and artificial intelligence capabilities as the consumer health company looks to accelerate its global “Win as One” strategy.
LONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer health company solely focused on better everyday health, today announces a new five-year collaboration with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global Win as One strategy. The new agreement builds on Haleon's existing use of Microsoft 365 Copilot and further supports the wider adoption of AI-powered tools across the business, helping teams automate routine tasks, collaborate more effe.
12:30pm: Tech strength The Nasdaq continued to lead stocks higher in the early afternoon on Monday, up 1.4% while the S&P 500 was up 0.8% and the Dow Jones...
Share in Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) rose 19% to 0.6p after it ended its US partnership with consumer health giant Haleon PLC (LSE:HLN,...
Key metrics vs top competitors for Haleon plc (HLN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.84 | $43.82B | 20.41 | -3.96% | 15.11% | 9.98% | 1.81% | |
| $19.78 | $37.98B | 26.03 | -2.14% | 10.61% | 15.18% | — | |
| $98.95 | $23.44B | 32.76 | 1.57% | 11.81% | 17.45% | — | |
| $152.75 | $356.94B | 23.46 | 0.29% | 14.66% | 23.78% | — | |
| $95.03 | $76.04B | 36.13 | 1.4% | 10.04% | 265.78% | — | |
| $50.42 | $2.39B | 12.90 | -4.31% | 17.48% | 10.29% | — |
Haleon plc (HLN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when HLN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Haleon plc (HLN) stock FAQ — growth, dividends, profitability & financials explained
Haleon plc (HLN) reported $22.01B in revenue for fiscal year 2025. This represents a 160% increase from $8.48B in 2019.
Haleon plc (HLN) saw revenue decline by 4.0% over the past year.
Yes, Haleon plc (HLN) is profitable, generating $3.18B in net income for fiscal year 2025 (15.1% net margin).
Yes, Haleon plc (HLN) pays a dividend with a yield of 1.81%. This makes it attractive for income-focused investors.
Haleon plc (HLN) has a return on equity (ROE) of 10.0%. This is below average, suggesting room for improvement.
Haleon plc (HLN) generated $3.12B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
